{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:36:43Z","timestamp":1765291003011,"version":"3.46.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Principal Investigators Project of Yichang Central People's Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04515-8","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:32:55Z","timestamp":1765290775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of botulinum toxin injection for sialorrhea in amyotrophic lateral sclerosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Ju","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuojuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhong","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6023-0081","authenticated-orcid":false,"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"4","key":"4515_CR1","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1016\/j.jpainsymman.2021.12.005","volume":"63","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang X, Han Q, Liu M, Zhou C. Prevalence of sialorrhea among amyotrophic lateral sclerosis patients: A systematic review and Meta-Analysis. J Pain Symptom Manage Apr. 2022;63(4):e387\u201396. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.12.005.","journal-title":"J Pain Symptom Manage Apr"},{"key":"4515_CR2","doi-asserted-by":"publisher","unstructured":"McHenry KL. Airway clearance strategies and secretion management in amyotrophic lateral sclerosis. Respir Care. 2024(2). https:\/\/doi.org\/10.4187\/respcare.11215.","DOI":"10.4187\/respcare.11215"},{"issue":"4","key":"4515_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1600-0714.2008.00727.x","volume":"38","author":"C Scully","year":"2009","unstructured":"Scully C, Limeres J, Gleeson M, Tom\u00e1s I, Diz P. Drooling. J Oral Pathol Med. 2009;38(4):321\u20137. https:\/\/doi.org\/10.1111\/j.1600-0714.2008.00727.x.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"4515_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/cnd.0000000000000273","volume":"21","author":"L Shehee","year":"2020","unstructured":"Shehee L, O\u2019Rourke A, Garand KL. The role of radiation therapy and botulinum toxin injections in the management of sialorrhea in patients with amyotrophic lateral sclerosis: A systematic review. J Clin Neuromuscul Dis Jun. 2020;21(4):205\u201321. https:\/\/doi.org\/10.1097\/cnd.0000000000000273.","journal-title":"J Clin Neuromuscul Dis Jun"},{"issue":"5","key":"4515_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006981.pub3","volume":"20","author":"E James","year":"2022","unstructured":"James E, Ellis C, Brassington R, Sathasivam S, Young CA. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis. Cochrane Database Syst Rev. 2022;20(5):Cd006981. https:\/\/doi.org\/10.1002\/14651858.CD006981.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"4515_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00513","volume":"11","author":"H Singh","year":"2020","unstructured":"Singh H, Nene Y, Mehta TR, Govindarajan R. Efficacy of botulinum toxin for treating sialorrhea in neuromuscular conditions. Front Neurol. 2020;11:513. https:\/\/doi.org\/10.3389\/fneur.2020.00513.","journal-title":"Front Neurol"},{"issue":"9","key":"4515_CR7","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1007\/s10072-023-06881-y","volume":"44","author":"TA Cantisani","year":"2023","unstructured":"Cantisani TA. Is there a treatment effective and safe for sialorrhea in people with amyotrophic lateral sclerosis (ALS)? Summary of a Cochrane systematic review. Neurol Sci Sep. 2023;44(9):3083\u20135. https:\/\/doi.org\/10.1007\/s10072-023-06881-y.","journal-title":"Neurol Sci Sep"},{"issue":"2","key":"4515_CR8","first-page":"116","volume":"21","author":"WA Abboud","year":"2019","unstructured":"Abboud WA, Nadel S, Hassin-Baer S, Arad A, Dobriyan A, Yahalom R. Ultrasound-guided botulinum toxin injections into the salivary glands for the treatment of drooling. Isr Med Assoc J. 2019;21(2):116\u20139.","journal-title":"Isr Med Assoc J"},{"key":"4515_CR9","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https:\/\/doi.org\/10.1136\/bmj.n160.","journal-title":"BMJ"},{"issue":"1","key":"4515_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/jnnp.69.1.121","volume":"69","author":"R Giess","year":"2000","unstructured":"Giess R, Naumann M, Werner E, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry Jul. 2000;69(1):121\u20133. https:\/\/doi.org\/10.1136\/jnnp.69.1.121.","journal-title":"J Neurol Neurosurg Psychiatry Jul"},{"issue":"5","key":"4515_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/s1808-8694(15)31258-1","volume":"71","author":"D Manrique","year":"2005","unstructured":"Manrique D. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis. Braz J Otorhinolaryngol. 2005;71(5):566\u20139. https:\/\/doi.org\/10.1016\/s1808-8694(15)31258-1.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"2","key":"4515_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.cnd.0000188865.88167.62","volume":"7","author":"KR Scott","year":"2005","unstructured":"Scott KR, Kothari MJ, Venkatesh YS, Murphy T, Simmons Z. Parotid gland injections of botulinum toxin A are effective in treating sialorrhea in amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2005;7(2):62\u20135. https:\/\/doi.org\/10.1097\/01.cnd.0000188865.88167.62.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"2","key":"4515_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mus.20545","volume":"34","author":"A Verma","year":"2006","unstructured":"Verma A, Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve. 2006;34(2):235\u20137. https:\/\/doi.org\/10.1002\/mus.20545.","journal-title":"Muscle Nerve"},{"issue":"5","key":"4515_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.parkreldis.2006.05.005","volume":"13","author":"MF Contarino","year":"2007","unstructured":"Contarino MF, Pompili M, Tittoto P, et al. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson\u2019s disease. Parkinsonism Relat Disord. 2007;13(5):299\u2013303. https:\/\/doi.org\/10.1016\/j.parkreldis.2006.05.005.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"4515_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00415-008-0738-5","volume":"255","author":"J Costa","year":"2008","unstructured":"Costa J, Rocha ML, Ferreira J, Evangelista T, Coelho M, de Carvalho M. Botulinum toxin type-B improves sialorrhea and quality of life in Bulbaronset amyotrophic lateral sclerosis. J Neurol. 2008;255(4):545\u201350. https:\/\/doi.org\/10.1007\/s00415-008-0738-5.","journal-title":"J Neurol"},{"issue":"2","key":"4515_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/mus.21213","volume":"39","author":"CE Jackson","year":"2009","unstructured":"Jackson CE, Gronseth G, Rosenfeld J, et al. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle Nerve. 2009;39(2):137\u201343. https:\/\/doi.org\/10.1002\/mus.21213.","journal-title":"Muscle Nerve"},{"issue":"4","key":"4515_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/17482960903264998","volume":"11","author":"F Gilio","year":"2010","unstructured":"Gilio F, Iacovelli E, Frasca V, et al. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study. Amyotroph Lateral Scler. 2010;11(4):359\u201363. https:\/\/doi.org\/10.3109\/17482960903264998.","journal-title":"Amyotroph Lateral Scler"},{"issue":"18","key":"4515_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2146\/ajhp100343","volume":"15","author":"E Rodriguez-Murphy","year":"2011","unstructured":"Rodriguez-Murphy E, Marti-Bonmati E, Camps-Segu\u00ed E, Bag\u00e1n JV. Manually guided botulinum toxin type A submandibular injections for the treatment of sialorrhea in tube-fed patients with advanced amyotrophic lateral sclerosis. Am J Health-Syst Pharm. 2011;15(18):1680\u20131. https:\/\/doi.org\/10.2146\/ajhp100343.","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"4515_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/mus.23692","volume":"47","author":"E Anagnostou","year":"2013","unstructured":"Anagnostou E, Rentzos M, Alexakis T, Zouvelou V, Zambelis T, Evdokimidis I. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis. Muscle Nerve Feb. 2013;47(2):276\u20138. https:\/\/doi.org\/10.1002\/mus.23692.","journal-title":"Muscle Nerve Feb"},{"issue":"3","key":"4515_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/ane.12559","volume":"134","author":"JG Weikamp","year":"2016","unstructured":"Weikamp JG, Schinagl DA, Verstappen CC, Schelhaas HJ, de Swart BJ, Kalf JG. Botulinum toxin-A injections vs radiotherapy for drooling in ALS. Acta Neurol Scand Sep. 2016;134(3):224\u201331. https:\/\/doi.org\/10.1111\/ane.12559.","journal-title":"Acta Neurol Scand Sep"},{"key":"4515_CR21","doi-asserted-by":"publisher","unstructured":"Paracka L, Kollewe K, Klietz M, Petri S, Dressler D. IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis. Toxicon. 2018;156(S120). https:\/\/doi.org\/10.1016\/j.toxicon.2018.11.288. Conference Abstract.","DOI":"10.1016\/j.toxicon.2018.11.288"},{"key":"4515_CR22","doi-asserted-by":"publisher","unstructured":"Rushkevich Y, Charnenka N, Likhachev S. AbobotulinumtoxinA in amyotrophic lateral sclerosis patients with sialorrhea. Toxicon. 2021;190(S66). https:\/\/doi.org\/10.1016\/j.toxicon.2020.11.483. Conference Abstract.","DOI":"10.1016\/j.toxicon.2020.11.483"},{"issue":"2","key":"4515_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.16821\/j.cnki.hsix.2018.02.006","volume":"33","author":"YG YF Z","year":"2018","unstructured":"YF Z YG. JBI critical appraisal tools for different types of research: quality appraisal of interventional studies (Part II). J Nurses Train. 2018;33(2):112\u20133. https:\/\/doi.org\/10.16821\/j.cnki.hsix.2018.02.006.","journal-title":"J Nurses Train"},{"issue":"10","key":"4515_CR24","doi-asserted-by":"publisher","first-page":"Ed000142","DOI":"10.1002\/14651858.Ed000142","volume":"3","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev Oct. 2019;3(10):Ed000142. https:\/\/doi.org\/10.1002\/14651858.Ed000142.","journal-title":"Cochrane Database Syst Rev Oct"},{"issue":"7454","key":"4515_CR25","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"Grading quality of evidence and strength of recommendations","year":"2004","unstructured":"Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. https:\/\/doi.org\/10.1136\/bmj.328.7454.1490.","journal-title":"BMJ"},{"issue":"7414","key":"4515_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"5","key":"4515_CR27","doi-asserted-by":"publisher","first-page":"R585","DOI":"10.1152\/ajpregu.00455.2014","volume":"309","author":"D Tomassoni","year":"2015","unstructured":"Tomassoni D, Traini E, Mancini M, Bramanti V, Mahdi SS, Amenta F. Dopamine, vesicular transporters, and dopamine receptor expression in rat major salivary glands. Am J Physiol Regul Integr Comp Physiol Sep. 2015;309(5):R585\u201393. https:\/\/doi.org\/10.1152\/ajpregu.00455.2014.","journal-title":"Am J Physiol Regul Integr Comp Physiol Sep"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04515-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04515-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04515-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:32:57Z","timestamp":1765290777000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04515-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4515"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04515-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}